Pharmacogenomic information in FDA-approved drug labels: Application to pediatric patients

Pharmacogenomic (PGx) information is increasingly being incorporated into US Food and Drug Administration‐approved drug labels. We reviewed the data source (adults vs. pediatrics) of PGx information in approved drug labels and assessed the suitability of applying adult‐derived PGx information and re...

Full description

Saved in:
Bibliographic Details
Published in:Clinical pharmacology and therapeutics 2016-06, Vol.99 (6), p.622-632
Main Authors: Green, DJ, Mummaneni, P, Kim, IW, Oh, JM, Pacanowski, M, Burckart, GJ
Format: Article
Language:English
Subjects:
Adult
Child
Drug Approval
Drug Labeling - legislation & jurisprudence
Drug Prescriptions - standards
Genetic Markers
Humans
Patient Education as Topic
Pediatrics - standards
Pharmacogenetics
Pharmacogenomic Testing
United States
United States Food and Drug Administration - standards
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pharmacogenomic (PGx) information is increasingly being incorporated into US Food and Drug Administration‐approved drug labels. We reviewed the data source (adults vs. pediatrics) of PGx information in approved drug labels and assessed the suitability of applying adult‐derived PGx information and related prescribing recommendations to the care of pediatric patients. We identified 65 drugs with labels containing PGx information and that have also been evaluated in children and found that in the majority of cases (56/65, 86%), the PGx information described was derived from adult studies. The application of PGx information from adults to pediatrics was deemed suitable for 71.4% (n = 40) of the drugs and unclear for 28.6% (n = 16). An ontogeny effect, limited or conflicting data regarding ontogeny of the genetic biomarker, or a difference in the pathophysiology or progression of the adult vs. pediatric disease were the primary reasons for deeming direct application from adults to pediatrics unclear.
ISSN:0009-9236
1532-6535
DOI:10.1002/cpt.330